+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Risk assessment of p53 genotypes and haplotypes in tobacco-associated leukoplakia and oral cancer patients from eastern Idia



Risk assessment of p53 genotypes and haplotypes in tobacco-associated leukoplakia and oral cancer patients from eastern Idia



International Journal of Cancer 117(5): 786-793



The role of 3 p53 polymorphisms (16 bp duplication at intron 3, codon 72 Arg/Pro and intron 6 NciI RFLP at np 13494) as potential markers for indicating cancer risk remains inconclusive. In our case-control study consisting of 197 leukoplakia and 310 oral squamous cell carcinoma (SCC) patients and 348 controls, genotype frequencies at these 3 p53 loci were determined by PCR-RFLP method and analyzed by multiple logistic regression to determine the risks of the diseases. The 2/2 genotype at codon 72 of p53 was at risk for developing leukoplakia (OR = 1.6, 95% CI 1.1-2.3), whereas the combination of 1/2 and 2/2 genotypes at intron 3 and 1/1 and 1/2 genotypes at intron 6 conferred a protective effect against leukoplakia and oral SCC development, respectively (OR = 0.5, 95% CI 0.4-0.8 and OR = 0.6, 95% CI 0.5-0.9, respectively). When subjects were stratified according to specific tobacco habit, the risk/protection estimates improved significantly in some cases. Specifically, the exclusive smokers with p53 codon 72 2/2 genotype showed a higher risk of developing leukoplakia (OR = 2.7, 95% CI 1.2-6.3). Furthermore, a particular p53 haplotype 1-2-2 was at risk for both tobacco-associated leukoplakia and oral SCC (OR = 1.5, 95% CI 1.1-1.9 and OR = 1.3, 95% CI 1.1-1.7, respectively). Our results show that both specific p53 genotype and haplotype can indicate risk of tobacco-associated leukoplakia, but risk of development of tobacco-associated oral SCC can be predicted by specific p53 haplotype only.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 050222410

Download citation: RISBibTeXText

PMID: 15981211

DOI: 10.1002/ijc.21263


Related references

Increased risk of oral leukoplakia and cancer among mixed tobacco users carrying XRCC1 variant haplotypes and cancer among smokers carrying two risk genotypes: one on each of two loci, GSTM3 and XRCC1 (Codon 280). Cancer Epidemiology, Biomarkers & Prevention 14(9): 2106-2112, 2005

Risk Assessment of Smokeless Tobacco among Oral Precancer and Cancer Patients in Eastern Developmental Region of Nepal. Asian Pacific Journal of Cancer Prevention 20(2): 411-415, 2019

Risk assessment of smokeless tobacco among oral precancer and cancer patients in eastern developmental region of Nepal. International Journal of Oral & Maxillofacial Surgery 44: E130-E131, 2015

Glutathione S-transferase M1 and T1 null genotypes as risk factors for oral leukoplakia in ethnic Indian betel quid/tobacco chewers. Carcinogenesis 20(5): 743-748, 1999

Biochemical changes of saliva in tobacco chewers tobacco smokers, alcohol consumers, leukoplakia and oral cancer patients. Indian Journal of Dental Research 13(2): 102-107, 2002

Associations of genotypes and haplotypes of IL-17 with risk of gastric cancer in an eastern Chinese population. Oncotarget 7(50): 82384-82395, 2016

Polymorphisms at p53, p73, and MDM2 loci modulate the risk of tobacco associated leukoplakia and oral cancer. Molecular Carcinogenesis 48(9): 790-800, 2009

Glutathione S-transferase M3 (A/A) genotype as a risk factor for oral cancer and leukoplakia among Indian tobacco smokers. International Journal of Cancer 109(1): 95-101, 2004

CYP1A1 genotypes and haplotypes and risk of oral cancer: A case-control study in South Indians. Genetics and Molecular Biology 35(2): 407-412, 2012

Variant haplotypes at XRCC1 and risk of oral leukoplakia in HPV non-infected samples. Journal of Oral Pathology and Medicine 38(2): 174-180, 2008

Quantitative prediction of oral cancer risk in patients with oral leukoplakia. Oncotarget 8(28): 46057-46064, 2017

P53 genotypes and haplotypes with a potentially predictive value for risk assessment and retroviral p53 transduction for gene therapy of breast cancer. Klijn, J G M European School of Oncology Scientific Updates, Vol 1; Prognostic and predictive value of p53 143-160, 1997

Low prevalence of high risk genotypes of human papilloma virus in normal oral mucosa, oral leukoplakia and verrucous carcinoma. Acta Odontologica Scandinavica 69(6): 406-409, 2012

Comprehensive SNP scan of DNA repair and DNA damage response genes reveal multiple susceptibility loci conferring risk to tobacco associated leukoplakia and oral cancer. Plos One 8(2): E56952, 2013

An epidemiologic assessment of cancer risk in oral precancerous lesions in India with special reference to nodular leukoplakia. Cancer 63(11): 2247-2252, 1989